GlassScriptPhysician profile
Alyxandra Soloway Craner
NPI 1376170530
$4,017.14
in general payments reported to CMS, 2019-2025
18 companies · $3,181 in 2025
The $3,181 reported for 2025 was more than what 78% of Rheumatology providers received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $836 · 2025: $3,181.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,617 · Education: $300 · Consulting Fee: $100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,617.17 |
| Education | $299.97 |
| Consulting Fee | $100.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $878.62 | 2024-2025 | Evenity, Otezla, Prolia |
| Genzyme Corporation | $687.20 | 2024-2025 | |
| Abbvie INC. | $488.74 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $331.77 | 2024-2025 | |
| Janssen Biotech, INC. | $302.83 | 2025 | Tremfya, Simponi Aria |
| Sobi, INC | $245.04 | 2024-2025 | |
| Sanofi-Aventis U.S. LLC | $199.98 | 2024-2025 | |
| Glaxosmithkline, LLC. | $152.52 | 2025 | Benlysta |
| Astrazeneca Pharmaceuticals LP | $127.50 | 2025 | Saphnelo |
| Ucb, INC. | $125.68 | 2025 | Bimzelx |
| Mallinckrodt Hospital Products INC. | $125.24 | 2025 | Acthar |
| Cardinal Health 110 LLC | $100.00 | 2025 | |
| Kyowa Kirin, INC. | $88.38 | 2025 | |
| Kiniksa Pharmaceuticals International, Plc | $46.69 | 2024 | Arcalyst |
| Radius Health, INC. | $46.08 | 2025 | Tymlos |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $32.61 | 2025 | |
| Lilly USA, LLC | $19.69 | 2025 | Taltz |
| Fresenius Kabi USA, LLC | $18.57 | 2025 | Tyenne |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alyxandra Soloway Craner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.